Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01698905
Title Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

chronic myeloid leukemia

Therapies

Nilotinib

Age Groups: adult
Covered Countries USA | FRA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
USC Kenneth Norris Comprehensive Cancer Center USC Los Angeles California 90033 United States Details
Indiana Blood and Marrow Institute SC Beech Grove Indiana 46107 United States Details
St. Agnes Hospital SC Baltimore Maryland 21229 United States Details
University of Texas Medical Branch SC Galveston Texas 77555-1188 United States Details
Compass Oncology Vancouver Washington 98683 United States Details
Novartis Investigative Site Caba Buenos Aires C1221ADC Argentina Details
Novartis Investigative Site Buenos Aires C1114AAN Argentina Details
Novartis Investigative Site Adelaide South Australia 5000 Australia Details
Novartis Investigative Site Box Hill Victoria 3128 Australia Details
Novartis Investigative Site Antwerp 2060 Belgium Details
Novartis Investigative Site Goiania GO 74605-050 Brazil Details
Novartis Investigative Site Belo Horizonte MG 30130-100 Brazil Details
Novartis Investigative Site Rio de Janeiro RJ 20.211-030 Brazil Details
Novartis Investigative Site Rio De Janiero RJ 20231-050 Brazil Details
Novartis Investigative Site Porto Alegre RS 90035-003 Brazil Details
Novartis Investigative Site Campinas SP Brazil Details
Novartis Investigative Site Hamilton Ontario L8V 5C2 Canada Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Montreal Quebec H1T 2M4 Canada Details
Novartis Investigative Site Quebec G1J 1Z4 Canada Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Grenoble 38043 France Details
Novartis Investigative Site Lyon Cedex 69373 France Details
Novartis Investigative Site Strasbourg cedex 67085 France Details
Novartis Investigative Site Vandoeuvre les Nancy 54511 France Details
Novartis Investigative Site Mannheim Baden-Wuerttemberg 68305 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Heilbronn 74072 Germany Details
Novartis Investigative Site Potsdam 14467 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Larissa GR 411 10 Greece Details
Novartis Investigative Site Athens 106 76 Greece Details
Novartis Investigative Site Athens 18547 Greece Details
Novartis Investigative Site Haifa 3109601 Israel Details
Novartis Investigative Site Petach Tikva 4910002 Israel Details
Novartis Investigative Site Ramat Gan 52621 Israel Details
Novartis Investigative Site Nagoya Aichi 464 8681 Japan Details
Novartis Investigative Site Narita Chiba 286-8523 Japan Details
Novartis Investigative Site Fukuoka city Fukuoka 812-8582 Japan Details
Novartis Investigative Site Kurume city Fukuoka 830-0011 Japan Details
Novartis Investigative Site Akita 010-8543 Japan Details
Novartis Investigative Site Aomori 030 8553 Japan Details
Novartis Investigative Site Chiba 260 8677 Japan Details
Novartis Investigative Site Seoul Seocho Gu 06591 Korea, Republic of Details
Novartis Investigative Site Monterrey Nuevo Leon 64718 Mexico Details
Novartis Investigative Site Krakow Malopolskie 30-510 Poland Details
Novartis Investigative Site Gdansk 80-952 Poland Details
Novartis Investigative Site Warszawa 02 776 Poland Details
Novartis Investigative Site Moscow 125167 Russian Federation Details
Novartis Investigative Site St Petersburg 191024 Russian Federation Details
Novartis Investigative Site St Petersburg 197341 Russian Federation Details
Novartis Investigative Site Singapore 169608 Singapore Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Santander Cantabria 39008 Spain Details
Novartis Investigative Site Badalona Catalunya 08916 Spain Details
Novartis Investigative Site Alicante Comunidad Valenciana 03010 Spain Details
Novartis Investigative Site La Laguna Santa Cruz De Tenerife 38320 Spain Details
Novartis Investigative Site Madrid 28006 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28046 Spain Details
Novartis Investigative Site Liverpool L7 8XP United Kingdom Details
Novartis Investigative Site Nottingham NG5 United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field